Advanced search
Sort by:
selected
Print page
Email selected articles
Favourite selected articles
Create a NED Search Alert for this search
Save this search
Advanced Search
Run an advanced search
URL of your articles

Please copy the URL below to share your selected articles.

Copy to clipboard

Please select at least one article to create a URL for.
Email articles

Enter the email address/es to which you would like to email these articles to. Separate multiple emails by comma's.

Email/s

Please select at least one article to email.
Create a NED Search Alerts

You need to be logged in to create NED Search Alerts. Register here.
Save a search

You need to be logged in to save searches. Register here.

Filters

Clear all
Expert Opinion
plain language summary logo
Plain Language Summary
Expert Review
Text Availability
Abstract
10
Full text
9
Free full text
5
Publication Types
Journal Article
11
Review
4
Research Support, Non-U.S. Gov't
4
Clinical Trial
2
Randomized Controlled Trial
2
Clinical Trial, Phase III
1
Research Support, U.S. Gov't, P.H.S.
1
Historical Article
1
Observational Study
1
Equivalence Trial
1
Multicenter Study
1
Publication Year
From
To
Quick links
Individual year
2025
1
2024
1
2022
1
2017
1
2016
1
2011
1
2005
1
2004
1
2003
1
2001
1
2000
1

Results for
""Clofazimine""[mesh_terms]

11 Results
Searching titles within these results

Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.

Helena Huerga, Uzma Khan, Mathieu Bastard, Carole D Mitnick, Nathalie Lachenal, Palwasha Y Khan, Kwonjune J Seung, Nara Melikyan, Saman Ahmed, Michael L Rich, Francis Varaine, Elna Osso, Makhmujan Rashitov, Naseem Salahuddin, Gocha Salia, Epifanio Sánchez, Armine Serobyan, Muhammad Rafi Siddiqui, Dri Grium Tefera, Dmitry Vetushko, Lusine Yeghiazaryan, David Holtzman, Shirajul Islam, Andargachew Kumsa, Gamarly Jacques Leblanc, Olga Leonovich, Shahid Mamsa, Mohammad Manzur-Ul-Alam, Zaw Myint, Shrivani Padayachee, Molly F Franke, Catherine Hewison

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022;75(8):1307-1314

Free Full Text
Abstract

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial.

Lorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, Maelenn Gouillou, Muhammad Hammad Ali, Samreen Amjad, Farees Kamal, Amanzhan Abubakirov, Elisa Ardizzoni, Elisabeth Baudin, Sagit Bektassov, Catherine Berry, Maryline Bonnet, Vijay Chavan, Sylvine Coutisson, Zhanna Dakenova, Bouke Catherine de Jong, Luong Van Dinh, Gabriella Ferlazzo, Ohanna Kirakosyan, Nathalie Lachenal, Leonid Lecca, Helen McIlleron, Kwabisha Kunda Mikanda, Sergio Mucching-Toscano, Wim Mulders, Hebah Mushtaque, Payam Nahid, Dong Van Nguyen, Nhung Viet Nguyen, Lawrence Oyewusi, Ilaria Motta, Samiran Panda, Sandip Patil, Thuong Huu Pham, Dat Thuong Phan, Ha Thi Thu Phan, Patrick P J Phillips, Jimena Ruiz, Praharshinie Rupasinghe, Naseem Salahuddin, Epifanio Sanchez-Garavito, Kwonjune J Seung, Meseret Tamirat Asfaw, Dante Vargas Vasquez, Michael L Rich, Francis Varaine, Carole D Mitnick

The Lancet. Respiratory medicine 2025;13(9):809-820

Free Full Text
Abstract
Results: 1 – 11 / 11
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor Sponsor Sponsor Sponsor Sponsor Sponsor Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.